What will you achieve with mRNA? Life-changing medicines, vaccines and more made possible by the latest improvements in mRNA and LNP technology.
See specific examples of applications by going to our application articles: Application articles
See how our products have been used by customers, by going to our customer articles: Customer articles
What is mRNA used for?
There are many therapeutic applications that use mRNA. Some common ones are: Stem cell therapy, crop science, vaccines, immuno-oncology, rare metabolic disorders, bone generation, gene editing, antibody therapy, cultivated meat and chromic kidney disease.
If you want to see more specific examples on how our products have been used by customers, go to our customer articles by clicking the button.
These RIBOPRO application articles demonstrate a few cases on how our products can be applied across different projects.
We are in awe of the work our customers do with our products. To honor this work, we have constructed this hall of fame, which also serves as a repository to learn from each other. What worked for them, may also work for you.
Addressing the determinants of ambiguous assignments incurred by the mass spectrometry sequence analysis of large modified RNAs
Hybrid lipid nanoparticles derived from human mesenchymal stem cell extracellular vesicles by microfluidic sonication for collagen I mRNA delivery to human tendon progenitor stem cells
Impact of formulation and process parameters on the stability and bioactivity of RNA-loaded lipid nanoparticles during nebulization
Hybrid lipid nanoparticles derived from human mesenchymal stem cell extracellular vesicles by microfluidic sonication for collagen I mRNA delivery to human tendon progenitor stem cells
A novel micelleplex for tumour-targeted delivery of CRISPR-Cas9 against KRAS-mutated lung cancer
Anionic polymer coating for enhanced delivery of Cas9 mRNA and sgRNA nanoplexes
IL-15 transpresentation by ovarian cancer cells improves CD34+ progenitor-derived NK cell’s anti-tumor functionality
Local mRNA Delivery from Nanocomposites Made of Gelatin and Hydroxyapatite Nanoparticles.
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors
OligoDOMTM: a T-cell response-enhancing platform applied to cancer immunotherapy
Optimizing mRNA delivery: A microfluidic exploration of DOTMA vs. DOTAP lipid nanoparticles for GFP expression on human PBMCs and THP-1 cell line
Sustained early postnatal humoral and cellular immunity against human cytomegalovirus after transamniotic fetal mRNA vaccination in a rodent model
